1. ScholarBank@NUS

Wang Tingting

rp02923

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wang Tingting
(not current staff)
Variants
Wang, T.
Wang, T.T.
 
Main Affiliation
 
Faculty
 
Email
csiwtt@nus.edu.sg
 

Publications

Results 1-12 of 12 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
11-Jan-2014AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancerDunne, P.D.; McArt, D.G.; Blayney, J.K.; Kalimutho, M.; Greer, S.; Wang, T. ; Srivastava, S. ; Ong, C.W. ; Arthur, K.; Loughrey, M.; Redmond, K.; Longley, D.B.; Salto-Tellez, M.; Johnston, P.G.; Van Schaeybroeck, S.
22010Computer-assisted pathological immunohistochemistry scoring is more time-effective than conventional scoring, but provides no analytical advantageOng, C.W. ; Kim, L.G. ; Soong, R. ; Salto-Tellez, M. ; Wang, T.T. ; Supriya, S. ; Kathiresan, M. ; Kong, H.H.; Low, L.Y.
31-Jan-2023FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sitesThuya, WL ; Kong, LR ; Syn, NL; Ding, LW ; Cheow, ESH ; Wong, RTX ; Wang, T ; Goh, RMWJ; Song, H ; Jayasinghe, MK; Le, MTN; Hu, JC; Yong, WP ; Lee, SC ; Wong, ALA ; Sethi, G ; Hung, HT ; Ho, PCL ; Thiery, JP ; Sze, SK ; Guo, T; Soo, RA ; Yang, H; Lim, YC ; Wang, L ; Goh, BC 
42016High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancerWang, T ; Srivastava, S ; Hartman, M ; Buhari, S.A ; Chan, C.-W ; Iau, P; Khin, L.W ; Wong, A ; Tan, S.-H ; Goh, B.-C ; Lee, S.-C 
52010ITIH3 Is a potential biomarker for early detection of gastric cancerChong, P.K. ; Lee, H.; Zhou, J. ; Liu, S.-C.; Loh, M.C.S. ; Wang, T.T. ; Lim, Y.P. ; Chan, S.P.; Smoot, D.T.; Ashktorab, H.; So, J.B.Y. ; Lim, K.H.; Yeoh, K.G. 
6Dec-2012Lgr5 expression is absent in human premalignant lesions of the stomachWang, T. ; Yeoh, K.G.; Salto-Tellez, M. 
7Dec-2013One-step nucleic acid amplification assay also predicts axillary lymph node status in breast cancer patients: Further molecular diagnostic evidenceWang, T. ; Buhari, S.A.; Pang, B.; Putti, T.C.; Salto-Tellez, M. 
82016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C. 
923-Aug-2011Sequential expression of putative stem cell markers in gastric carcinogenesisWang, T. ; Ong, C.W. ; Shi, J. ; Srivastava, S. ; Yan, B.; Cheng, C.L.; Yong, W.P. ; Chan, S.L.; Yeoh, K.G.; Iacopetta, B.; Salto-Tellez, M. 
102016Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathwayWang, T ; Seah, S ; Loh, X ; Chan, C.-W ; Hartman, M ; Goh, B.-C ; Lee, S.-C 
11May-2012Stem cell markers characterise familial adenomatous polyposisWang, T. ; Yeoh, K.G.; Salto-Tellez, M. 
122015Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenibWong A.L.A. ; Lim J.S.J. ; Sinha A. ; Gopinathan A. ; Lim R.; Tan C.-S. ; Soh T.; Venkatesh S.; Titin C.; Sapari N.S. ; Lee S.-C. ; Yong W.-P. ; Tan D.S.P. ; Pang B. ; Wang T.-T. ; Zee Y.-K.; Soong R. ; Trnkova Z.; Lathia C.; Thiery J.-P.; Wilhelm S.; Jeffers M.; Goh B.-C.